Stay updated on AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.3.2, updated from v3.2.0. No study details or user-facing content appear to be affected.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page no longer displays the general government operating status notice, and all trial-specific content (title, identifiers, eligibility criteria, locations, and study plan) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedThe AVP-786 study for agitation in Alzheimer's disease is terminated, with recruitment stopped and no participants currently being treated.SummaryDifference0.2%

- Check63 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%

- Check70 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.3%

- Check84 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1. The Back to Top element has been removed.SummaryDifference0.2%

Stay in the know with updates to AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.